Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ALPANASDAQ:APYXNASDAQ:DRIONASDAQ:FEMY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALPAAlpha Healthcare Acquisition Corp. III$3.14$8.73▼$11.83$8.92M0.03128,666 shs85,427 shsAPYXApyx Medical$2.16-3.6%$1.50$0.76▼$20.00$81.63M1.2180,982 shs54,013 shsDRIODarioHealth$0.67-2.2%$0.71$0.50▼$1.55$29.79M1.58286,285 shs93,280 shsFEMYFemasys$0.98-0.3%$1.01$0.69▼$1.80$25.04M-2.62262,929 shs233,810 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALPAAlpha Healthcare Acquisition Corp. III0.00%0.00%0.00%0.00%-65.26%APYXApyx Medical0.00%+8.00%+36.71%+57.66%+61.19%DRIODarioHealth0.00%-2.90%-6.69%+9.44%-43.70%FEMYFemasys0.00%+15.29%+11.35%-21.60%-14.04%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALPAAlpha Healthcare Acquisition Corp. IIIN/AN/AN/AN/AN/AN/AN/AN/AAPYXApyx Medical2.446 of 5 stars0.05.00.04.22.21.70.6DRIODarioHealth1.8611 of 5 stars3.30.00.00.02.60.81.3FEMYFemasys3.6579 of 5 stars3.55.00.00.03.22.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALPAAlpha Healthcare Acquisition Corp. III 0.00N/AN/AN/AAPYXApyx Medical 2.67Moderate BuyN/AN/ADRIODarioHealth 2.67Moderate Buy$2.00198.51% UpsideFEMYFemasys 3.00Buy$8.67784.35% UpsideCurrent Analyst Ratings BreakdownLatest ALPA, APYX, FEMY, and DRIO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/25/2025FEMYFemasysHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$12.006/11/2025FEMYFemasysHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$12.005/19/2025DRIODarioHealthLitchfield Hills ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$3.005/13/2025FEMYFemasysJones TradingSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$10.00 ➝ $6.005/9/2025FEMYFemasysHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $12.00(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALPAAlpha Healthcare Acquisition Corp. IIIN/AN/AN/A923.23($0.31) per shareN/AAPYXApyx Medical$48.10M1.70N/AN/A$0.38 per share5.68DRIODarioHealth$27.04M1.10N/AN/A$2.11 per share0.32FEMYFemasys$1.63M15.36N/AN/A$0.10 per share9.80Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALPAAlpha Healthcare Acquisition Corp. III$200KN/A0.00N/AN/AN/A-28.55%0.84%N/AAPYXApyx Medical-$23.46M-$0.55N/AN/AN/A-42.37%-156.85%-31.92%8/6/2025 (Estimated)DRIODarioHealth-$42.75M-$0.56N/AN/AN/A-159.80%-65.81%-38.41%8/6/2025 (Estimated)FEMYFemasys-$18.82M-$0.91N/AN/AN/A-1,242.06%-392.45%-137.15%8/14/2025 (Estimated)Latest ALPA, APYX, FEMY, and DRIO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025DRIODarioHealth-$0.07-$0.14-$0.07-$0.14$7.48 million$6.75 million5/8/2025Q1 2025APYXApyx Medical-$0.13-$0.10+$0.03-$0.10$9.39 million$9.43 million5/8/2025Q1 2025FEMYFemasys-$0.17-$0.23-$0.06-$0.23$1.14 million$0.34 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALPAAlpha Healthcare Acquisition Corp. IIIN/AN/AN/AN/AN/AAPYXApyx MedicalN/AN/AN/AN/AN/ADRIODarioHealthN/AN/AN/AN/AN/AFEMYFemasysN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALPAAlpha Healthcare Acquisition Corp. IIIN/A0.050.05APYXApyx Medical3.215.454.64DRIODarioHealth0.262.011.77FEMYFemasys0.020.930.54Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALPAAlpha Healthcare Acquisition Corp. III67.49%APYXApyx Medical55.33%DRIODarioHealth33.39%FEMYFemasys65.27%Insider OwnershipCompanyInsider OwnershipALPAAlpha Healthcare Acquisition Corp. III0.39%APYXApyx Medical15.20%DRIODarioHealth11.20%FEMYFemasys11.54%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALPAAlpha Healthcare Acquisition Corp. III2,02119.31 millionN/ANot OptionableAPYXApyx Medical27037.79 million32.05 millionOptionableDRIODarioHealth20044.46 million39.48 millionOptionableFEMYFemasys3025.55 million22.60 millionNot OptionableALPA, APYX, FEMY, and DRIO HeadlinesRecent News About These CompaniesFemasys Inc. Receives CE Mark Certification for Revolutionary FemBloc® System for Non-Surgical Permanent Birth Control - NasdaqJune 27 at 8:24 PM | nasdaq.comFemasys (NASDAQ:FEMY) Given Buy Rating at HC WainwrightJune 27 at 2:39 AM | americanbankingnews.comFemasys Gains European Approval for FemBloc SystemJune 26, 2025 | msn.comFemasys Approves Director Elections and Share IncreaseJune 25, 2025 | tipranks.comFemasys Inc. Receives CE Mark Certification for Revolutionary FemBloc® System for Non-Surgical Permanent Birth ControlJune 25, 2025 | quiverquant.comQFemasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth ControlJune 25, 2025 | globenewswire.comFemasys Appoints Kelley Nicholas as Chief Commercial OfficerJune 17, 2025 | tipranks.comFemasys Names New Chief Commercial Officer to Drive Execution and Global GrowthJune 17, 2025 | globenewswire.comFemasys Partners with Carolinas Fertility Institute to Enhance Access to FemaSeed® as First-Line Infertility TreatmentJune 13, 2025 | nasdaq.comFemasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best Fertility Clinics, to Offer FemaSeed® in its More than 8 LocationsJune 12, 2025 | taiwannews.com.twTFemasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best ...June 11, 2025 | bakersfield.comBThe Analyst Verdict: Femasys In The Eyes Of 6 ExpertsJune 11, 2025 | benzinga.comFemasys Announces Partnership with Carolinas Fertility Institute, One of America's Best Fertility Clinics, to Offer FemaSeed® in its More than 8 LocationsJune 11, 2025 | globenewswire.comFemasys Announces $4.5 Mln Offering Through Public Sale And Private Placement Of SharesJune 1, 2025 | nasdaq.comFemasys Announces Pricing of Underwritten Public Offering and Concurrent Private Placement with Gross Proceeds of $4.5 MillionMay 30, 2025 | finance.yahoo.comFemasys Stock Slides After Company Prices Public Offering At Discount: Retail’s Planning To Load UpMay 30, 2025 | msn.comFemasys Announces Proposed Public Offering of Common Stock and Concurrent Private PlacementMay 29, 2025 | globenewswire.comFemasys faces potential delisting from NasdaqMay 24, 2025 | uk.investing.com7FEMY : Analyst Expectations For Femasys's FutureMay 9, 2025 | benzinga.comFemasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue EstimatesMay 8, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeALPA, APYX, FEMY, and DRIO Company DescriptionsAlpha Healthcare Acquisition Corp. III NASDAQ:ALPAAlpha Healthcare Acquisition Corp. III does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.Apyx Medical NASDAQ:APYX$2.16 -0.08 (-3.57%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$2.29 +0.13 (+6.06%) As of 04:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.DarioHealth NASDAQ:DRIO$0.67 -0.02 (-2.20%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$0.67 0.00 (0.00%) As of 06/27/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.Femasys NASDAQ:FEMY$0.98 0.00 (-0.33%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$1.04 +0.06 (+6.63%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
